Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
26.07.-29.07.2016
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report date:
2016

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Deviations:
yes
Remarks:
One tissue was rejected from evaluation due to having much higher OD570 than the other two. As absorbances of these two tissues were close together and not close to cut-off value, this deviation had no impact on the outcome of the study.
GLP compliance:
yes (incl. QA statement)

Test material

Constituent 1
Chemical structure
Reference substance name:
1,3-dimethyl-1,3-diphenylurea
EC Number:
210-283-4
EC Name:
1,3-dimethyl-1,3-diphenylurea
Cas Number:
611-92-7
Molecular formula:
C15H16N2O
IUPAC Name:
1,3-dimethyl-1,3-diphenylurea
Test material form:
solid: particulate/powder

In vitro test system

Test system:
human skin model
Source species:
human
Cell type:
other: normal human-derived epidermal keratinocytes
Cell source:
skin obtained from plastic surgery from multiple donors
Details on test system:
RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: model EpiDermTM
- Tissue: The reconstructed human epidermal model EpiDerm™ (EPI-200 ver. 2.0, MatTek, Bratislava, Slovakia); Lot No. 23347 kitL)
- Date of initiation of testing: 26.7.2016

TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37±1°C


Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount(s) applied: 25 g

NEGATIVE CONTROL
PBS (phosphate buffered saline) prepared 25/02/2016, exp. 25/08/2016 and prepared 23/03/2016 exp. 23/09/2016
- Amount(s) applied: 25 µL


POSITIVE CONTROL
5 % SDS (sodium dodecyl sulphate), MatTek, Lot No. 012616TMB, exp. 26/01/2017
Duration of treatment / exposure:
60 min.
Duration of post-treatment incubation (if applicable):
42 hours
Number of replicates:
3

Results and discussion

In vitro

Results
Irritation / corrosion parameter:
% tissue viability
Value:
100
Negative controls validity:
valid
Positive controls validity:
valid

Any other information on results incl. tables

Table No. 1: OD570values obtained at the MTT test, their averages, standard deviations (%) and relative viabilities

 

Treatment

OD570

Avg

SD

Average viability

 

1

2

3

 

 

(% NC)

NC

 

PBS

1.926

1.806

1.646

1.793

0.115

100.0 

viability (%)

107.4

100.7

91.8

100.0

6.4

C4

 

322/16

1.763

1.822

2.942

1.793

0.030

100.0 

viability (%)

98.3

101.6

164.1

100.0

1.6

PC

 

5% SDS

0.052

0.052

0.046

0.050

0.003

2.8

viability (%)

2.9

2.9

2.6

2.8

0.16

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
Under the above-described experimental design, average viability of tissues treated by the test substance Methylcentralit was 100.0 % of negative control average value. No correction was done.
The test item is considered to have no category:
(ii) if the tissue viability after exposure and post-treatment incubation is more than (>) 50 %.
Even if the value obtained lay close cut-off value for the test, the effect of the test item was negative in EpiDermTM model.
According to the classification criteria given in chapter 4.5. of this report, the test item, Methylcentralit, is considered to have no category in accordance with UN GHS 1.


Executive summary:

The test item, Methylcentralit, was assayed for the in vitro skin irritation
in human epidermal model EpiDermTM.The test was performed according tothe OECD Test Guideline No.439:In VitroSkin Irritation: Reconstructed Human Epidermis Test Method (2015) and Protocol for: In Vitro EpiDermTMSkin Irritation Test For use with MatTek Corporation’s Reconstructed Human Epidermal Model EPI-200-SIT (see par. 1.4).

After pre-incubation of tissues, 25 mg of the test substance was placed directly a top to the previously moistened tissue and it was spread on the entire tissue surface. Length of exposition was 60 minutes. Three tissues were used for the test substance and every control.

After removal of the test substance, tissues were post-incubated for approximately 42 hours due to leave of damage reparation. Three hours incubation with MTT and two hours extraction period with shaking followed then. Optical density (OD570) of isopropyl alcohol extracts was measured on a spectrophotometer. Relative cell viability was calculated for each tissue as % of the mean viability of the negative control tissues.

Isopropyl alcohol extract of one of three tissues was much higher than those of the other two. The outlying tissue was rejected from evaluation.

Average viability of the two evaluated treated tissues was 100.0% i.e. viability was >50 %.

The effect of the test item was negative in EpiDermTMmodel (tissues were not damaged).

According to the classification criteria given in chapter 4.5.,the test item, Methylcentralit, is considered to have no categoryin regard to skin irritation.